2025-04-012026-03-312026-03-31false08852661I & A RADIOLOGY LTD2026-10-14falseiso4217:GBPxbrli:pure088526612025-03-31088526612026-03-31088526612025-04-012026-03-31088526612024-03-31088526612025-03-31088526612024-04-012025-03-3108852661bus:SmallEntities2025-04-012026-03-3108852661bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3108852661bus:FullAccounts2025-04-012026-03-3108852661bus:PrivateLimitedCompanyLtd2025-04-012026-03-3108852661core:WithinOneYear2026-03-3108852661core:AfterOneYear2026-03-3108852661core:WithinOneYear2025-03-3108852661core:AfterOneYear2025-03-3108852661core:ShareCapital2026-03-3108852661core:SharePremium2026-03-3108852661core:RevaluationReserve2026-03-3108852661core:OtherReservesSubtotal2026-03-3108852661core:RetainedEarningsAccumulatedLosses2026-03-3108852661core:ShareCapital2025-03-3108852661core:SharePremium2025-03-3108852661core:RevaluationReserve2025-03-3108852661core:OtherReservesSubtotal2025-03-3108852661core:RetainedEarningsAccumulatedLosses2025-03-3108852661core:LandBuildings2026-03-3108852661core:PlantMachinery2026-03-3108852661core:Vehicles2026-03-3108852661core:FurnitureFittings2026-03-3108852661core:OfficeEquipment2026-03-3108852661core:NetGoodwill2026-03-3108852661core:IntangibleAssetsOtherThanGoodwill2026-03-3108852661core:ListedExchangeTraded2026-03-3108852661core:UnlistedNon-exchangeTraded2026-03-3108852661core:LandBuildings2025-03-3108852661core:PlantMachinery2025-03-3108852661core:Vehicles2025-03-3108852661core:FurnitureFittings2025-03-3108852661core:OfficeEquipment2025-03-3108852661core:NetGoodwill2025-03-3108852661core:IntangibleAssetsOtherThanGoodwill2025-03-3108852661core:ListedExchangeTraded2025-03-3108852661core:UnlistedNon-exchangeTraded2025-03-3108852661core:LandBuildings2025-04-012026-03-3108852661core:PlantMachinery2025-04-012026-03-3108852661core:Vehicles2025-04-012026-03-3108852661core:FurnitureFittings2025-04-012026-03-3108852661core:OfficeEquipment2025-04-012026-03-3108852661core:NetGoodwill2025-04-012026-03-3108852661core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3108852661core:ListedExchangeTraded2025-04-012026-03-3108852661core:UnlistedNon-exchangeTraded2025-04-012026-03-3108852661core:MoreThanFiveYears2025-04-012026-03-3108852661core:Non-currentFinancialInstruments2026-03-3108852661core:Non-currentFinancialInstruments2025-03-3108852661dpl:CostSales2025-04-012026-03-3108852661dpl:DistributionCosts2025-04-012026-03-3108852661core:LandBuildings2025-04-012026-03-3108852661core:PlantMachinery2025-04-012026-03-3108852661core:Vehicles2025-04-012026-03-3108852661core:FurnitureFittings2025-04-012026-03-3108852661core:OfficeEquipment2025-04-012026-03-3108852661dpl:AdministrativeExpenses2025-04-012026-03-3108852661core:NetGoodwill2025-04-012026-03-3108852661core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3108852661dpl:GroupUndertakings2025-04-012026-03-3108852661dpl:ParticipatingInterests2025-04-012026-03-3108852661dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3108852661core:ListedExchangeTraded2025-04-012026-03-3108852661dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3108852661core:UnlistedNon-exchangeTraded2025-04-012026-03-3108852661dpl:CostSales2024-04-012025-03-3108852661dpl:DistributionCosts2024-04-012025-03-3108852661core:LandBuildings2024-04-012025-03-3108852661core:PlantMachinery2024-04-012025-03-3108852661core:Vehicles2024-04-012025-03-3108852661core:FurnitureFittings2024-04-012025-03-3108852661core:OfficeEquipment2024-04-012025-03-3108852661dpl:AdministrativeExpenses2024-04-012025-03-3108852661core:NetGoodwill2024-04-012025-03-3108852661core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3108852661dpl:GroupUndertakings2024-04-012025-03-3108852661dpl:ParticipatingInterests2024-04-012025-03-3108852661dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3108852661core:ListedExchangeTraded2024-04-012025-03-3108852661dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3108852661core:UnlistedNon-exchangeTraded2024-04-012025-03-3108852661core:NetGoodwill2026-03-3108852661core:IntangibleAssetsOtherThanGoodwill2026-03-3108852661core:LandBuildings2026-03-3108852661core:PlantMachinery2026-03-3108852661core:Vehicles2026-03-3108852661core:FurnitureFittings2026-03-3108852661core:OfficeEquipment2026-03-3108852661core:AfterOneYear2026-03-3108852661core:WithinOneYear2026-03-3108852661core:ListedExchangeTraded2026-03-3108852661core:UnlistedNon-exchangeTraded2026-03-3108852661core:ShareCapital2026-03-3108852661core:SharePremium2026-03-3108852661core:RevaluationReserve2026-03-3108852661core:OtherReservesSubtotal2026-03-3108852661core:RetainedEarningsAccumulatedLosses2026-03-3108852661core:NetGoodwill2025-03-3108852661core:IntangibleAssetsOtherThanGoodwill2025-03-3108852661core:LandBuildings2025-03-3108852661core:PlantMachinery2025-03-3108852661core:Vehicles2025-03-3108852661core:FurnitureFittings2025-03-3108852661core:OfficeEquipment2025-03-3108852661core:AfterOneYear2025-03-3108852661core:WithinOneYear2025-03-3108852661core:ListedExchangeTraded2025-03-3108852661core:UnlistedNon-exchangeTraded2025-03-3108852661core:ShareCapital2025-03-3108852661core:SharePremium2025-03-3108852661core:RevaluationReserve2025-03-3108852661core:OtherReservesSubtotal2025-03-3108852661core:RetainedEarningsAccumulatedLosses2025-03-3108852661core:NetGoodwill2024-03-3108852661core:IntangibleAssetsOtherThanGoodwill2024-03-3108852661core:LandBuildings2024-03-3108852661core:PlantMachinery2024-03-3108852661core:Vehicles2024-03-3108852661core:FurnitureFittings2024-03-3108852661core:OfficeEquipment2024-03-3108852661core:AfterOneYear2024-03-3108852661core:WithinOneYear2024-03-3108852661core:ListedExchangeTraded2024-03-3108852661core:UnlistedNon-exchangeTraded2024-03-3108852661core:ShareCapital2024-03-3108852661core:SharePremium2024-03-3108852661core:RevaluationReserve2024-03-3108852661core:OtherReservesSubtotal2024-03-3108852661core:RetainedEarningsAccumulatedLosses2024-03-3108852661core:AfterOneYear2025-04-012026-03-3108852661core:WithinOneYear2025-04-012026-03-3108852661core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3108852661core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3108852661core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3108852661core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3108852661core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3108852661core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3108852661core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3108852661core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3108852661core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3108852661core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3108852661core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3108852661core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3108852661core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3108852661core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3108852661core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3108852661core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3108852661core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3108852661core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3108852661core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3108852661core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3108852661core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3108852661core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3108852661core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3108852661core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3108852661core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3108852661core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3108852661core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3108852661bus:Director12025-04-012026-03-3108852661bus:Director22025-04-012026-03-31

I & A RADIOLOGY LTD

Registered Number
08852661
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

I & A RADIOLOGY LTD
Company Information
for the year from 1 April 2025 to 31 March 2026

Directors

ANOSIKE, Chinedum Ndubuisi, Dr
ANOSIKE, Ndidi

Registered Address

3 Glazebrook Lane
Widnes
WA8 5BP

Registered Number

08852661 (England and Wales)
I & A RADIOLOGY LTD
Balance Sheet as at
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets31,2891,438
1,2891,438
Current assets
Debtors58,29412,270
Cash at bank and on hand55,94041,028
64,23453,298
Creditors amounts falling due within one year6(9,326)(6,224)
Net current assets (liabilities)54,90847,074
Total assets less current liabilities56,19748,512
Provisions for liabilities7(245)(273)
Net assets55,95248,239
Capital and reserves
Called up share capital100100
Profit and loss account55,85248,139
Shareholders' funds55,95248,239
The financial statements were approved and authorised for issue by the Board of Directors on 14 October 2026, and are signed on its behalf by:
ANOSIKE, Chinedum Ndubuisi, Dr
Director
Registered Company No. 08852661
I & A RADIOLOGY LTD
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Office Equipment25
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
2.Average number of employees

20262025
Average number of employees during the year32
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 April 255,5935,593
Additions248248
At 31 March 265,8415,841
Depreciation and impairment
At 01 April 254,1554,155
Charge for year397397
At 31 March 264,5524,552
Net book value
At 31 March 261,2891,289
At 31 March 251,4381,438
4.Stocks
5.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables6,3947,131
Other debtors-5,139
Prepayments and accrued income1,900-
Total8,29412,270
6.Creditors: amounts due within one year

2026

2025

££
Taxation and social security7,2834,880
Other creditors466-
Accrued liabilities and deferred income1,5771,344
Total9,3266,224
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
7.Provisions for liabilities

2026

2025

££
Net deferred tax liability (asset)245273
Total245273